PHU V TRUONG MD NPI 1558323758

NPI Details

Phu V Truong, MD is a hematology and oncology internal medicine in Wichita, KS with 27 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Phu V Truong, MD NPI is 1558323758. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF KANSAS SCHOOL OF MED (KC/WICH/SAL)
Graduation Year:1999

The provider's business location address is:

3243 E MURDOCK ST
SUITE 300
WICHITA, KS
ZIP 67208-052
Phone: (316) 262-4467
Fax: (316) 262-0706

The NPI 1558323758 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
• Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, nivolumab, 1 mg (HCPCS:J9299)
• Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram (HCPCS:Q5110)
• Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
• Injection, paclitaxel protein-bound particles, 1 mg (HCPCS:J9264)
• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
• Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg (HCPCS:Q5107)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Microscopic examination for white blood cells with manual cell count (HCPCS:85007)
• Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection, granisetron, extended-release, 0.1 mg (HCPCS:J1627)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Injection, pegfilgrastim-jmdb, biosimilar, (fulphila), 0.5 mg (HCPCS:Q5108)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Unclassified drugs (HCPCS:J3490)
• Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
• Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
• Magnesium level (HCPCS:83735)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Total protein level, urine (HCPCS:84156)
• Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Ct scan of chest with contrast (HCPCS:71260)
• Folic acid level, serum (HCPCS:82746)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Drawing of blood for a medical problem (HCPCS:99195)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Phosphate level (HCPCS:84100)
• Administration of chemotherapy into vein using push technique (HCPCS:96409)
• Infusion, normal saline solution, 250 cc (HCPCS:J7050)
• Alpha-fetoprotein (afp) level, serum (HCPCS:82105)
• Red blood count automated, with additional calculations (HCPCS:85046)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml (HCPCS:Q9965)
• Ct scan of abdomen and pelvis before and after contrast (HCPCS:74178)
• Injection of drug or substance into vein (HCPCS:96374)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Ct scan of chest without contrast (HCPCS:71250)
• Manual urinalysis test with examination using microscope, non-automated (HCPCS:81000)
• Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
• Uric acid level, blood (HCPCS:84550)
• Influenza vaccine, quadrivalent, 0.5 ml dosage (HCPCS:90688)
• Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
• Administration of influenza virus vaccine (HCPCS:G0008)

The enumeration date for this NPI number is 4/4/2006 and was last updated on 9/29/2011.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.